Peptides containing a fusion joint of a chimeric protein encoded

Details Peptides containing a fusion joint of a chimeric protein encoded Peptides containing a fusion joint of a chimeric protein encoded

1995-09-14

1999-12-07

Scheiner, Laurie

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

4241851, 4241921, 530300, 530326, 530327, A61K 3900, A61K 3800, A61K 3804

Patent

active

059978694

ABSTRACT:
A method of immunizing a mammal against a tumor cell by exposing splenic or peripheral blood mononuclear cells to a peptide that encompasses a fusion joint of a fusion protein encoded by DNA spanning a human chromosomal translocation associated with Ewing's sarcoma (t(11;22)(q24;q12)) or alveolar rhabdomyosarcoma (t(2:13)(q35;q14)) is provided.

REFERENCES:
Abastado et al., "Fine Mapping of Epitopes by Intradomain K.sup.d /D.sup.d Recombinants," Journal of Experimental Medicine, 166:327-340 (Aug. 1987).
Aichele et al., "Antiviral Cytotoxic T Cell Repsonse Induced by in Vivo Priming With a Free Synthetic Peptide," J. Exp. Med., 171:1815-1820 (May 1990).
Alexander et al., "Correlation Between CD8 Dependency and Determinant Density Using Peptide-Induced, L.sup.d -restricted Cytotoxic T Lympphocytes," J. Exp. Med., 173:849-858 (Apr. 1991).
Ashwell et al., "Antigen Presentation by Resting B Cells Radiosensitivity of the Antigen-Presentation Function and Two Distinct Pathways of T Cell Activation," J. Exp. Med., 159:881-905 (Mar. 1984).
Bennink et al., "Recombinant Vaccinia Virus Primes and Stimulates Influenza Haemagglutinin-Specific Cyto-Toxic T Cells," Nature, 311:578-579 (Oct. 1994).
Bhattacharya et al., "A Shared Alloantigenic Determinant on Ia Antigens Encoded by the I-A and I-E Sub-Regions: Evidence . . . ," The Journal of Immunology, 127:2488-2495 (Dec. 1981).
Boog et al., "Role of Dendritic Cells in the Regulation of Class I Restricted Cytotoxic T Lymphocyte Responses," The Journal of Immunology, 140:3331-3337 (May 15, 1988).
Carbone et al., "Induction of Cytotoxic T Lymphocytes by Primary in Vitro Stimulation With Peptides," J. Exp. Med., 167:1767-1779 (Jun. 1988).
Caron et al., "TP53 Tumor Suppressor Gene: A Model for Investigating Human Mutagenesis," Genes, Chromosomes & Cancer, 4:1-15 (1992) .
Cease et al., "T Cell Clones Specific for an Amphipathic .alpha.-Helical Region of Sperm Whale Myoglobin Show Differing Fine Specificies for Synthetic Peptides," J. Exp. Med., 164:1779-1784 (Nov. 1986).
Ceredig et al., "Expression of Interleukin-2 Receptors as A Differentiation Marker on Intrathymic Stem Cells," Nature, 314:98-100 (Mar. 1985).
Chakrabarti et al., "Expression of the HTLV-III Envelope Gene by a Recombinant Vaccinia Virus," Nature, 320:535-537 (Apr. 1986).
Chen et al., "Human Papillomavirus Type 16 Nucleoprotein E7 is a Tumor Rejection Antingen," Proc. Natl. Acad. Sci. USA 88:110-114 (Jan. 1991).
Chesnut et al., "Studies on the Capacity of B Cells to Serve as Antigen-Presenting Cells," The Journal of Immunology, 126:1075-1079 (Mar. 1981).
Chiba et al., "Mutations in the p53 Gene are Frequent in Primary, Resected Non-Small Cell Lung Cancer," Oncogene, 5:1603-1610 (1990).
Chung et al., "Probing the Structure and Mechanism of Ras Protein with an Expanded Genetic Code," Science, 259:806-809 (Feb. 5, 1993).
Clerici et al., "Detection of Cytotoxic T Lymphocytes Specific for Synthetic Peptides of gp160 in HIV-Seropositive Individuals," The Journal of Immunology, 146:2214-2219 (Apr. 1, 1991).
Cornette et al., "Identification of T-Cell Epitopes and Use in Construction of Sythetic Vaccines," Methods in Enzymology, 178:611-634 (1989).
D'Amico et al., "High Frequency of Somatically Acquired p53 Mutations in Small-Cell Lung Cancer Cell Lines and Tumors," Oncogene, 7:339-346 (Feb. 1992).
Debrick et al., "Macrophages as Accessory Cells for Class I MHC-Restricted Immune Responses," The Journal of Immunology, 147:2846-2851 (Nov. 1, 1991).
DeLisi et al., "T-Cell Antigenic Sites Tend to be Amphipathic Structures," Proc. Natl. Acad. Sci. USA, 82:7048-7052 (Oct. 1985).
Deres et al., "In Vivo Priming of Virus-Specific Cytotoxic T Lymphocytes with Synthetic Lipopeptide Vaccine," Nature, 342:561-564 (Nov. 30, 1989).
Deres et al., "Preferred Size of Peptides That Bind to H-2 K.sup.b is Sequence Dependent," Eur. J. Immunol., 22:1603-1608 (Jun. 1992).
Evans et al., "Structure and Expression of a Mouse Major Histocompatibility Antigen Gene, H-2L.sup.d," Proc. Natl. Acad. Sci. USA 79:1994-1998 (Mar. 1982).
Falk et al., "Allele-Specific Motifs Revealed by Sequencing of Self-Peptides Eluted from MHC Molecules," Nature, 351:290-296 (May 23, 1991).
Fremont et al., "Crystal Structures of Two Viral Peptides in Complex with Murine MHC Class I H-2k.sup.b," Science, 257:919-926 (Aug. 14, 1992).
Gao et al., "Priming of Influenza Virus-Specific Cytotoxic T Lymphocytes Vivo by Short Synthetic Peptides," Journal of Immunolgoy, 147:3268-3273 (Nov. 15, 1991).
Germain, "The Ins and Outs of Antigen Processing and Presentation," Nature, 322:687-689 (Aug. 1986).
Goudsmit et al., "Human Immunodeficiency Virus Type 1 Neutralization Epitope With Conserved Architecture Elicits Early Type-Specific Antibodies in . . . ," Proc. Natl. Acad. Sci. USA, 85:4478-4482 (Jun. 1988).
Guo et al., "Different Length Peptides Bind to HLA-Aw68 Similarly at Their Ends but Bulge Out in the Middle," Nature, 360:364-366 (Nov. 26, 1992).
Hart et al., "Priming of Anti-Human Immunodeficiency Virus (HIV) CD8+ Cytotoxic T Cells In Vivo by Carrier-Free HIV Synthetic Peptides," Proc. Nat. Acad. Sci. USA, 88:9448-9452 (Nov. 1991).
Harty et al., "CD8+ T Cells Specfiic for a Single Nonamer Epitope of Listeria Monocytogenes Are Protective In Vivo," J. Exp. Med., 175:1531-1538 (Jun. 1992).
Inaba et al., "Dendritic Cells Pulsed with Protein Antigens In Vitro Can Prime Antigen-Specific, MHC-Restricted T Cells In Situ," J. Exp. Med., 172:631-640 (Aug. 1990).
Jung et al., "Human T-Lymphocytes Recognize a Peptide of Single Point-Mutated, Oncogenic ras Proteins," J. Exp. Med., 173:273-276 (Jan. 1991).
Kast et al.,"Failure or Success in the Restoration of Virus-Specific Cytotoxic T Lymphocyte Response Defects by Dendritic Cells," The Journal of Immunology, 140:3186-3193 (May 1, 1988).
Kast et al., "Protection against lethal Sendai virus infection by in vivo priming of virus-specific cyto-toxic T Lymphocytes with a free synthetic peptide," Proc. Natl. Acad. Sci. USA, 88:2283-2287 (Mar. 1991).
Knight et al., "Non-adherent, low-density cells from human peripheral blood contain dendritic cells and monocytes, both with veiled morphology," Immunology, 57:595-603 (1986).
Levine et al., "The p53 tumour suprressor gene," Nature, 351:453-456 (Jun. 6, 1991).
Levine, "Tumor Suprressor Genes," BioEssays, 12:60-66 (Feb. 1990).
Lie et al., "Peptide Ligand-Induced Conformation and Surface Expression of the L.sup.d class I MHC Molecule," Nature, 344:439-441 (Mar. 29, 1990.)
Lotze et al., "Mechanisms of Immunologic Antitumor Therapy: Lessons from the Laboratory and Clinical Applications," Human Immunology, 28:198-207 (1990).
Macatonia et al., "Primary Stimulation by Dendritic Cells Induces Antiviral Proliferative and Cytotoxic T Cell Responses In Vitro," J. Exp. Med., 169:1255-1264 (Apr. 1989).
Margalit et al., "Prediction of Immunodominant Helper T Cell Antigenic Sites from the Primary Sequence," The Journal of Immunology, 138:2213-2229 (Apr. 1, 1987).
Margulies et al., Expression of H-2D.sup.d and H-2L.sup.d Mouse Major Histocompatability Antigen Genes in L Cells after DNA-Mediated Gene Transer, The Journal of Immunology, 130:463-470 (Jan. 1983).
Matis et al., "Clonal Analysis of the Major Histocompatibility Complex Restriction and the Fine Specificity of Antigen Recognition in the T cell . . . ," The Journal of Immunology, 130:1527-1535 (Apr. 1983).
Matsumura et al.,"Emerging Principles for the Recognition of Peptide Antigens by MHC Class I Molecules," Science, 257:927-934 (Aug. 14, 1992).
Mitsudomi et al., "p53 Gene Mutations in Non-Small-Cell Lung Cancer Cell Lines and Their Correlation with the Presence of ras Mutations and Clinical Features," Oncogene, 7:171-180 (Jan. 1992).
Monaco, "A Molecular Model of MHC Class-I-Restricted Antigen Processing," Immunology Today, 13:173-179 (1992).
Palker et al., "Type-Specific Neutralization of the Human Immunodeficiency Virus with Antibodies to env-Encoded Synthetic Peptides," Proc. Natl. Acad. Sci. USA, 85:1932-1936 (Mar. 1988).
Peace et al., "T Cell Recognition of Transforming Proteins Encoded by Mutated ras Proto-Oncogenes," Th

Affiliated with

Also associated with

Rating

Peptides containing a fusion joint of a chimeric protein encoded does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptides containing a fusion joint of a chimeric protein encoded, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides containing a fusion joint of a chimeric protein encoded will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-820601